Nuclear speckle dynamics are controlled by polyphosphate inhibition of CLK proteins
Nucleic Acids Research · 2026
DOI: 10.1093/nar/gkag309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Blanca Lázaro und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona 08195, Spain. Hauptthemen laut MEDLINE: Polyphosphates, Protein Serine-Threonine Kinases, Nuclear Speckles, Protein-Tyrosine Kinases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministerio de Ciencia e Innovación, Spanish Government, Universitat Internacional de Catalunya.
Abstract (Originalsprache)
Nuclear speckles (NS) are membraneless nuclear organelles that act as critical hubs for pre-messenger RNA splicing. Defects in splicing are linked to several human diseases, including cancer, Alzheimer’s disease, and dystrophies. While CLK kinases regulate the mobilization of splicing factors from NS, the molecular mechanisms underlying NS assembly and dissolution remain unclear. Using an adaptation of the Biotinylation by Antibody Recognition technique, we identified polyphosphate (polyP) as a novel and essential regulator of NS dynamics. Polyphosphate, a highly conserved polyanion composed of a chain of phosphate molecules, is involved in several functions in mammalian cells. Here, we show that polyP interacts with the NS core component SRRM2, and its depletion disrupts NS organization releasing splicing factors into the nucleoplasm. RNA-seq analysis reveals that polyP depletion increases exon exclusion, particularly in transcripts with multiple isoforms, highlighting its role in splicing regulation. Mechanistically, we demonstrate that polyP acts as a physiological inhibitor of CLK3 kinase, preventing the phosphorylation of SR proteins and thereby maintaining NS stability. Our findings not only expand our understanding of NS biology but also provide new insights into the polyP involvement in splicing-related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona 08195, Spain.
- Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, United Kingdom.
- Department of Medicine and Life Sciences, Faculty of Health and Life Sciences, Universitat Pompeu Fabra, Barcelona 08003, Spain.
- Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona 08003, Spain.
ORCID-Profile: Francisco J Tadeo, Filipy Borghi, Adolfo Saiardi, Javier Jiménez
Förderung
- Ministerio de Ciencia e Innovación
- Spanish Government
- Universitat Internacional de Catalunya
Zitieren
APA
Lázaro, B., Tadeo, F. J., Rodríguez, A., Ayuso-Molina, L., Martínez-Láinez, J. M., Quandt, E., Bernard, M., Borghi, F., Saiardi, A., Juan-Mateu, J., Jiménez, J., Clotet, J., & Bru, S. (2026). Nuclear speckle dynamics are controlled by polyphosphate inhibition of CLK proteins. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag309
Vancouver
Lázaro B, Tadeo FJ, Rodríguez A, Ayuso-Molina L, Martínez-Láinez JM, Quandt E, et al. Nuclear speckle dynamics are controlled by polyphosphate inhibition of CLK proteins. Nucleic Acids Research. 2026. doi:10.1093/nar/gkag309
BibTeX
@article{Lzaro2026,
author = {Lázaro, Blanca and Tadeo, Francisco J and Rodríguez, Andrea and Ayuso-Molina, Lucía and Martínez-Láinez, Joan Marc and Quandt, Eva and Bernard, Maribel and Borghi, Filipy and Saiardi, Adolfo and Juan-Mateu, Jonàs and Jiménez, Javier and Clotet, Josep and Bru, Samuel},
title = {Nuclear speckle dynamics are controlled by polyphosphate inhibition of CLK proteins},
journal = {Nucleic Acids Research},
year = {2026},
doi = {10.1093/nar/gkag309}
}
EUVIMED